160 results on '"Manotti C"'
Search Results
2. Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results
3. Cerebral venous sinus thrombosis in childhood: clinical aspects and neurological and cognitive long-term outcome in three cases
4. Low-oestrogen oral contraceptives as a major risk factor for cerebral venous and sinus thrombosis: evidence from a clinical series
5. The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers – two independent studies
6. Identification and role of the hemostasis and thrombosis expert in the National Health System
7. Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation -a look beyond the excellent results
8. ISAM: international study on anticoagulation management. The Italian experience
9. Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL
10. Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation
11. Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation
12. Variation in Hemostatic Parameters after Intra-Arterial and Intravenous Administration of Iodinated Contrast Media
13. Effect of a computer-aided management of treatment quality of anticoagulated patients: a prospective randomized multicenter trial. APROAT (Automated Program for Oral Anticoagulant Treatment)
14. Comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic diseases in patients with and without malignancy
15. A guide to oral anticoagulant treatment
16. Thrombotic events during oral anticoagulant treatment: results of the inception cohort prospective collaborative ISCOAT study
17. Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias
18. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy
19. Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab.
20. ChemInform Abstract: Synthesis and Antiplatelet Effects of 2-Amino-1,2-benzisothiazolin-3-one.
21. Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes
22. Effects of heparan-sulphate administration on clotting parameters and serum thromboxane B2 levels in cholesterol fed rabbits
23. Guidelines on management of nontherapeutic INRs: are really easy to apply in daily practice?
24. Computer Assisted Anticoagulant Therapy
25. Awareness of Teratogenic Effect of Oral Anticoagulants in Fertile Women
26. Doppler velocimetry and thrombophilic screening at middle trimester of gestation: preliminary data
27. A Simplified Procedure for Thromboplastin Calibration -The Usefulness of Lyophilized Plasmas Assessed in a Collaborative Study
28. Low Molecular Weight Heparin versus Warfarin in the Prevention of Recurrences after Deep Vein Thrombosis
29. Combined use of strain-gauge plethysmography and latex D-dimer test in clinically suspected deep venous thrombosis
30. Immunochemical characterization of an acquired inhibitor to FXIII
31. Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio
32. Subcutaneous vs Intravenous Heparin in the Treatment of Deep Venous Thrombosis – A Randomized Clinical Trial
33. Bilateral deep vein thrombosis in a pregnant woman with antithrombin III deficiency: Treatment of acute episodes and preparation for delivery with replacement treatment
34. Doppler velocimetry and thrombophilic screening at middle trimester of gestation: preliminary data
35. Pharmacology of Desmin (low molecular weight Dermatan sulphate) in healthy volunteers following intravenous bolus administration of different dosages (200, 400, 800 mg)
36. Predictive value of preoperative in vitro and in vivo studies for correct individual heparinization in cardiac surgery
37. Pharmacology of a New Low Molecular Weight Dermatan Sulphate (Desmin) in Healthy Volunteers: Repeated Daily Intramuscular Administration of 400 mg for a Week
38. Inherited Deficiency of Antithrombin III in Two Italian Families
39. Adenocarcinoma Della Prostata (Stadio C E D) Ed Emocoagulazione
40. Thromboembolic Manifestations and Congenital Factor V Deficiency: A Family Study
41. Guida alla terapia antitrombotica curata dalla Federazione Nazionale Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA)
42. Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment)
43. Consensus document of Italian Federation of Thrombosis Services (FCSA), Italian Society of Laboratory Medicine (SIMeL), SIBioC e Italian Committee for Standardization of Laboratory Tests (CISMEL) on laboratory monitoring of the therapy with novel oral anticoagulant drugs | Documento di consenso di Federazione dei Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA), Società Italiana di Medicina di Laboratorio (SIMeL), SIBioC e Comitato Italiano per la Standardizzazione dei Metodi Ematologici e di Laboratorio (CISMEL) sul monitoraggio di laboratorio dei pazienti in terapia con nuovi farmaci anticoagulanti orali
44. A guide to oral anticoagulant therapy
45. Normal Prostacyclin-Like Activity In A Patient With Thrombotic Thrombocytopenic Purpura
46. Thromboembolic Manifestations and Congenital Factor V Deficiency: A Family Study
47. Changes Induced by Venous Stasis on Factor VIII Activities (VIII:C; VIIIR.AG; VIIIR:WF) in Different Clinical Conditions
48. Clinical pharmacology of a new preparation of low molecular weight heparin
49. Multicenter evaluation of a new chromogenic factor X assay in plasma of patients on oral anticoagulants
50. ANTICOAGULANT AND ANTIGENIC LEVELS OF PROTEIN C AND PROTEIN S IN PATIENTS ON STABILIZED ORAL ANTICOAGULANT TREATMENT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.